Prognostic Outcomes in Acute Coronary Syndrome Patients Without Standard Modifiable Risk Factors: A Multi-Ethnic Study Of 8680 Asian Patients

Gwyneth Kong, Nicholas Chew, Cheng Han Ng, Yeung Jek Ho, Aaron Shengting, O Z H Lim, Anand Ambhore, Gavin Ng, William Kong, Kian Keong Poh, Roger Foo, James Yip, Tiong-Cheng Yeo, Adrian F. Low, Chi‐Hang Lee, Mark Y. Chan, Huay Cheem Tan, Poay-Huan LohResearch 2021 · DOI

Introduction

Clinical management of cardiovascular disease has long been anchored by the identification and control of "Standard Modifiable cardiovascular Risk Factors" (SMuRFs): hypertension, hypercholesterolemia, diabetes mellitus, and smoking. These factors are the cornerstones of risk stratification and primary prevention. However, a growing clinical phenomenon involves patients presenting with Acute Coronary Syndrome (ACS) who possess none of these traditional markers.

Recent studies in Western populations have suggested a "SMuRF-less paradox," where patients without these risk factors experience worse clinical outcomes than those with them. This study aims to determine if this paradox persists in a multi-ethnic Asian population, a demographic with distinct genetic profiles and lifestyle patterns that may influence cardiovascular pathology differently.

Methodology

This study utilized a large-scale clinical dataset from a major tertiary "hub-and-spoke" hospital network in Singapore. Researchers conducted a retrospective cohort analysis of 8,680 consecutive patients admitted for ACS between January 1, 2011, and March 31, 2021.

The cohort was multi-ethnic, reflecting Singapore's population: Chinese (61%), Malay (21.2%), and Indian (17.1%). Patients were classified as "SMuRF-less" if they had no history of hypertension, hypercholesterolemia, or diabetes, and were non-smokers. The primary endpoint was 30-day cardiovascular mortality. Secondary endpoints included all-cause mortality, readmission rates, cardiogenic shock, stroke, and heart failure. To ensure robust results, the team employed multivariable regression analysis, adjusting for age, sex, ethnicity, chronic kidney disease, ACS type (STEMI vs. NSTEMI), and the presence of high-risk coronary lesions.

Results and Survival Analysis

Of the total population studied, 746 patients (8.6%) were identified as SMuRF-less. Demographically, these patients were significantly younger (mean age 57 vs. 61 years) and had a lower prevalence of pre-existing comorbidities such as stroke and chronic kidney disease compared to the SMuRF group.

Despite their seemingly "healthier" profile, SMuRF-less patients presented with higher clinical severity. They exhibited significantly higher rates of ventricular arrhythmias and required more intensive interventions, including inotropic support and invasive mechanical ventilation.

The multivariable analysis confirmed that SMuRF-less status was an independent predictor of poor outcomes. These patients faced a 48% higher risk of cardiovascular mortality (HR 1.48, 95% CI 1.09–1.86, p=0.048). Furthermore, they were at significantly higher risk for cardiogenic shock (RR 1.31, 95% CI 1.09–1.52) and stroke (RR 2.51, 95% CI 1.67–3.34).

Survival analysis using Kaplan-Meier curves demonstrated that the divergence in cardiovascular mortality occurs very early—often within the first few days of admission.

Kaplan-Meier survival curves for 30-day cardiovascular mortality in SMuRF-less vs. SMuRF patients.

Discussion

The findings reveal a critical gap in current cardiovascular risk assessment. The "SMuRF-less paradox" in this Asian cohort highlights that the absence of traditional risk factors can lead to a deceptive sense of security for both patients and clinicians.

One potential driver for the worse outcomes is the "treatment gap." The study found that SMuRF-less patients were less likely to be prescribed guideline-directed medical therapies (GDMT) upon discharge, including statins, beta-blockers, and ACE-inhibitors/ARBs. This suggests that clinicians may perceive these patients as lower risk, leading to less aggressive secondary prevention.

The consistency of these results across Chinese, Malay, and Indian ethnicities suggests a biological or systemic driver that transcends specific ethnic backgrounds. The increased risk was particularly notable in men and those presenting with ST-segment elevation myocardial infarction (STEMI), the most acute form of heart attack.

Limitations and Future Directions

While this study provides strong evidence of increased risk in SMuRF-less patients, it is limited by its retrospective, single-center design. Additionally, the study focused on short-term (30-day) outcomes; long-term longitudinal data is necessary to understand if this risk profile persists over time.

Future research should investigate non-traditional risk factors that may be prevalent in this subgroup, such as elevated Lipoprotein(a), genetic predispositions, environmental stressors, or specific protein deficiencies. Identifying these "hidden" drivers is essential for developing targeted screening and treatment protocols.

Conclusion

In conclusion, ACS patients without standard modifiable risk factors represent an unexpectedly high-risk subgroup in the Asian population. Despite their younger age and fewer comorbidities, they suffer from higher mortality and complication rates. There is an urgent need for clinicians to recognize this paradox and ensure that SMuRF-less patients receive the same intensive monitoring and guideline-directed therapy as their counterparts with traditional risk factors.

Summary updated

Abstract

Abstract IMPORTANCE There are growing concerns that patients suffering from acute coronary syndrome (ACS) without standard modifiable cardiovascular risk factors (SMuRFs), including hypertension, hypercholesterolemia, diabetes and smoking, have increased mortality. OBJECTIVE This study examined the outcomes of ACS in patients without SMuRFs (termed SMuRF-less) in a multi-ethnic Asian population which remains unknown. DESIGN This retrospective study was conducted from 1 st January 2011 to 31 st March 2021. SETTING This study was conducted in a tertiary healthcare institution in Singapore. PARTICIPANTS Consecutive patients presenting with ACS disease were recruited in the study. EXPOSURE The outcomes of SMuRF-less patients were compared with SMuRF patients. MAIN OUTCOMES AND MEASURES The primary outcome was cardiovascular mortality. Secondary outcomes were all-cause mortality, readmission, cardiogenic shock, stroke and heart failure. Multivariable regression analysis adjusted for covariates including age, sex, ethnicity, chronic kidney disease, ACS type, cardiac arrest, and left main and/or left anterior descending coronary RESULTS Of the 8680 patients studied, 8.6% were SMuRF-less patients. SMuRF-less patients were significantly younger and had fewer comorbidities including stroke and chronic kidney disease, but higher rates of ventricular arrhythmias and inotropic or invasive ventilation requirement compared to the SMuRF group. Multivariable analysis showed higher rates of cardiovascular mortality (HR 1.48, 95% CI 1.09–1.86, p=0.048), cardiogenic shock (RR: 1.31, 95% CI 1.09–1.52, p=0.015) and stroke (RR: 2.51, 95% CI 1.67–3.34, p=0.030) in SMuRF-less patients compared to SMuRF patients. Both groups had similar readmission (RR: 1.10, 95% CI 0.87–1.39, p=0.413) and heart failure (RR: 0.82, 95% CI 0.56–1.21, p=0.326) rates. Kaplan-Meier curve showed higher 30-day cardiovascular mortality in the SMuRF-less group compared to SMuRF group (HR: 1.84, 95% CI 1.45-2.33, p<0.001), with similar significant trends found in men, STEMI patients, and the three Asian ethnicities. CONCLUSION AND RELEVANCE Although the proportion of ACS patients without standard risk factors in our Asian population is lower than those reported in the West, they also have worse short-term mortality compared to those with SMuRF. This calls for a global focus on the management of this unexpectedly high-risk subgroup of patients.
BibTeX
@inproceedings{kong2021prognostic,
  author = {Gwyneth Kong and Nicholas Chew and Cheng Han Ng and Yeung Jek Ho and Aaron Shengting and O Z H Lim and Anand Ambhore and Gavin Ng and William Kong and Kian Keong Poh and Roger Foo and James Yip and Tiong-Cheng Yeo and Adrian F. Low and Chi‐Hang Lee and Mark Y. Chan and Huay Cheem Tan and Poay-Huan Loh},
  title = {{Prognostic Outcomes in Acute Coronary Syndrome Patients Without Standard Modifiable Risk Factors: A Multi-Ethnic Study Of 8680 Asian Patients}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-941766/v1},
}
Figure